Cargando…
Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies
We used a hybrid transmission and economic model to evaluate the relative merits of stockpiling antiviral drugs and vaccine for pandemic influenza mitigation. In the absence of any intervention, our base-case assumptions generated a population clinical attack rate of 31.1%. For at least some paramet...
Autores principales: | Newall, Anthony T., Wood, James G., Oudin, Noemie, MacIntyre, C. Raina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957998/ https://www.ncbi.nlm.nih.gov/pubmed/20113551 http://dx.doi.org/10.3201/eid1602.090571 |
Ejemplares similares
-
Influenza-related hospitalisation and death in Australians aged 50 years and older
por: Newall, Anthony T., et al.
Publicado: (2008) -
Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach
por: Muscatello, David J., et al.
Publicado: (2013) -
Does influenza pandemic preparedness and mitigation require gain‐of‐function research?
por: Adam, Dillon C., et al.
Publicado: (2017) -
Effects of Internal Border Control on Spread of Pandemic Influenza
por: Wood, James G., et al.
Publicado: (2007) -
Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic
por: Wood, James, et al.
Publicado: (2009)